Food Allergy Treatment Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Allergen Type, By Drug Type, By Route of Administration, By End User, By Region & Competition, 2021-2031F

Description

The Global Food Allergy Treatment Market is projected to expand from USD 7.15 Billion in 2025 to USD 11.53 Billion by 2031, achieving a CAGR of 8.29%. This sector encompasses the development and commercialization of pharmaceutical interventions and immunotherapies aimed at desensitizing the immune system or managing acute anaphylactic reactions triggered by specific dietary proteins. The primary force driving this growth is the rapidly rising global prevalence of sensitization to allergens like peanuts, milk, and eggs, which creates a critical demand for effective clinical management strategies beyond simple avoidance. Furthermore, the recent regulatory approval and launch of biologic agents that facilitate desensitization are significantly boosting the sector by offering healthcare providers new mechanisms to reduce the severity of allergic reactions.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 7.15 Billion
Market Size 2031	USD 11.53 Billion
CAGR 2026-2031	8.29%
Fastest Growing Segment	Epinephrine
Largest Market	North America

However, the market confronts a major obstacle regarding the high cost of new therapies and a complicated reimbursement environment that frequently limits broad patient access. These financial hurdles often obstruct the equitable availability of life-altering treatments across various demographic groups. As reported by Food Allergy Research & Education in 2024, approximately 33 million individuals in the United States were living with life-threatening food allergies, underscoring a massive addressable market that remains partially restricted by affordability challenges.

Market Driver

The rapid adoption of innovative immunotherapies and biologics is fundamentally transforming the Global Food Allergy Treatment Market, shifting clinical care beyond mere avoidance tactics. This evolution is underpinned by recent regulatory achievements that provide medical professionals with the first pharmaceutical options capable of reducing reaction severity across multiple allergens simultaneously. For instance, Genentech reported in a February 2024 press release titled 'FDA Approves Xolair as First and Only Medicine for Children and Adults With One or More Food Allergies' that clinical trials showed 68% of patients treated with Xolair for 16 to 20 weeks could tolerate at least 600 mg of peanut protein without moderate to severe symptoms, compared to only 5% of the placebo group. Such strong efficacy data encourages the swift integration of biologic agents into standard treatment protocols, directly broadening the addressable market for therapeutic interventions.

Simultaneously, the increasing global prevalence of severe food allergies in both children and adults is heightening the urgency for these disease-modifying solutions. The market's trajectory is heavily influenced by a patient population facing life-threatening risks, resulting in a critical unmet need for treatments that prevent anaphylaxis. Data from the Centers for Disease Control and Prevention in 2024 indicates that at least 40% of children with food allergies have been treated in the emergency department for reactions, highlighting the condition's severity. This significant disease burden drives substantial commercial activity and development spending; as noted by DBV Technologies in their 'Third Quarter 2024 Financial Results' from November 2024, operating expenses reached $96.4 million for the first nine months of the year, primarily to support the advancement of pivotal clinical trials.

Market Challenge

The commercial expansion of the Global Food Allergy Treatment Market is significantly hindered by the high cost of novel therapies and a complex reimbursement landscape. Although pharmaceutical advancements provide new desensitization mechanisms, the extensive research and development investments required for these biologics compel manufacturers to set premium list prices. Consequently, health insurers often categorize these treatments as non-essential or place them in tiers with high out-of-pocket costs, creating a financial barrier that restricts patient adoption. This gap between clinical availability and economic accessibility limits the serviceable addressable market, as only a fraction of the diagnosed population can afford continuous therapy, thereby stalling revenue growth for manufacturers.

This financial friction is further exacerbated by the existing economic burden placed on families managing these conditions. The Asthma and Allergy Foundation of America estimated in 2025 that the inflation-adjusted annual economic cost of caring for children with food allergies was approximately $34 billion. This substantial figure illustrates the heavy financial load already borne by households, making the additional expense of high-priced pharmaceutical interventions untenable for many. As a result, the market struggles to convert high clinical demand into sustained therapeutic adoption.

Market Trends

The emergency response segment is undergoing a significant transition from traditional auto-injectors to needle-free alternatives, specifically with the commercialization of intranasal epinephrine sprays. This trend directly targets critical barriers such as needle phobia and device bulkiness, which have historically delayed the administration of life-saving medication during anaphylactic events. Manufacturers are currently utilizing aggressive pricing strategies and partnership models to ensure these novel delivery systems rapidly penetrate the market and become accessible to a broad patient base. For example, according to a September 2024 press release by GoodRx titled 'GoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy,' a strategic partnership was established to allow consumers to access a pack of two single-use neffy devices for $199 at over 70,000 pharmacies, significantly lowering the financial hurdle for this new technology.

At the same time, the market is seeing a surge in the development of Epicutaneous Immunotherapy (EPIT) platforms, which deliver micro-doses of allergens through the skin to induce tolerance with fewer systemic side effects than oral routes. This non-invasive approach is rapidly moving through late-stage clinical pipelines, aiming to provide a safer desensitization option for pediatric patients who may not tolerate the gastrointestinal side effects associated with oral immunotherapy. Reflecting the substantial scale of this clinical development, DBV Technologies announced in an October 2024 press release titled 'DBV Announces Positive Regulatory Updates for the Viaskin Peanut Patch' that the company successfully enrolled a total of 654 subjects in the Phase 3 VITESSE efficacy trial to evaluate the modified peanut patch in children.

Key Market Players

Aimmune Therapeutics
DBV Technologies
Regeneron
Sanofi
Nestle Health Science
Novartis
Immune Design
TanGenix
Allergen Labs
FARE-associated Innovators

Report Scope

In this report, the Global Food Allergy Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Food Allergy Treatment Market, By Allergen Type

Dairy Products
Poultry Product
Tree Nuts
Peanuts
Shellfish
Wheat
Soys
Other

Food Allergy Treatment Market, By Drug Type

Antihistamines
Epinephrine
Immunotherapy

Food Allergy Treatment Market, By Route of Administration

Oral
Parenteral
Other

Food Allergy Treatment Market, By End User

Hospital Pharmacies
Retail Pharmacies
Others

Food Allergy Treatment Market, By Region

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Food Allergy Treatment Market.

Available Customizations:

Global Food Allergy Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Food Allergy Treatment Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Allergen Type (Dairy Products, Poultry Product, Tree Nuts, Peanuts, Shellfish, Wheat, Soys, Other)
- 5.2.2. By Drug Type (Antihistamines, Epinephrine, Immunotherapy)
- 5.2.3. By Route of Administration (Oral, Parenteral, Other)
- 5.2.4. By End User (Hospital Pharmacies, Retail Pharmacies, Others)
- 5.2.5. By Region
- 5.2.6. By Company (2025)
5.3. Market Map

6. North America Food Allergy Treatment Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Allergen Type
- 6.2.2. By Drug Type
- 6.2.3. By Route of Administration
- 6.2.4. By End User
- 6.2.5. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Food Allergy Treatment Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Allergen Type
    - 6.3.1.2.2. By Drug Type
    - 6.3.1.2.3. By Route of Administration
    - 6.3.1.2.4. By End User
- 6.3.2. Canada Food Allergy Treatment Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Allergen Type
    - 6.3.2.2.2. By Drug Type
    - 6.3.2.2.3. By Route of Administration
    - 6.3.2.2.4. By End User
- 6.3.3. Mexico Food Allergy Treatment Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Allergen Type
    - 6.3.3.2.2. By Drug Type
    - 6.3.3.2.3. By Route of Administration
    - 6.3.3.2.4. By End User

7. Europe Food Allergy Treatment Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Allergen Type
- 7.2.2. By Drug Type
- 7.2.3. By Route of Administration
- 7.2.4. By End User
- 7.2.5. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Food Allergy Treatment Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Allergen Type
    - 7.3.1.2.2. By Drug Type
    - 7.3.1.2.3. By Route of Administration
    - 7.3.1.2.4. By End User
- 7.3.2. France Food Allergy Treatment Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Allergen Type
    - 7.3.2.2.2. By Drug Type
    - 7.3.2.2.3. By Route of Administration
    - 7.3.2.2.4. By End User
- 7.3.3. United Kingdom Food Allergy Treatment Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Allergen Type
    - 7.3.3.2.2. By Drug Type
    - 7.3.3.2.3. By Route of Administration
    - 7.3.3.2.4. By End User
- 7.3.4. Italy Food Allergy Treatment Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Allergen Type
    - 7.3.4.2.2. By Drug Type
    - 7.3.4.2.3. By Route of Administration
    - 7.3.4.2.4. By End User
- 7.3.5. Spain Food Allergy Treatment Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Allergen Type
    - 7.3.5.2.2. By Drug Type
    - 7.3.5.2.3. By Route of Administration
    - 7.3.5.2.4. By End User

8. Asia Pacific Food Allergy Treatment Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Allergen Type
- 8.2.2. By Drug Type
- 8.2.3. By Route of Administration
- 8.2.4. By End User
- 8.2.5. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Food Allergy Treatment Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Allergen Type
    - 8.3.1.2.2. By Drug Type
    - 8.3.1.2.3. By Route of Administration
    - 8.3.1.2.4. By End User
- 8.3.2. India Food Allergy Treatment Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Allergen Type
    - 8.3.2.2.2. By Drug Type
    - 8.3.2.2.3. By Route of Administration
    - 8.3.2.2.4. By End User
- 8.3.3. Japan Food Allergy Treatment Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Allergen Type
    - 8.3.3.2.2. By Drug Type
    - 8.3.3.2.3. By Route of Administration
    - 8.3.3.2.4. By End User
- 8.3.4. South Korea Food Allergy Treatment Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Allergen Type
    - 8.3.4.2.2. By Drug Type
    - 8.3.4.2.3. By Route of Administration
    - 8.3.4.2.4. By End User
- 8.3.5. Australia Food Allergy Treatment Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Allergen Type
    - 8.3.5.2.2. By Drug Type
    - 8.3.5.2.3. By Route of Administration
    - 8.3.5.2.4. By End User

9. Middle East & Africa Food Allergy Treatment Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Allergen Type
- 9.2.2. By Drug Type
- 9.2.3. By Route of Administration
- 9.2.4. By End User
- 9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Food Allergy Treatment Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Allergen Type
    - 9.3.1.2.2. By Drug Type
    - 9.3.1.2.3. By Route of Administration
    - 9.3.1.2.4. By End User
- 9.3.2. UAE Food Allergy Treatment Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Allergen Type
    - 9.3.2.2.2. By Drug Type
    - 9.3.2.2.3. By Route of Administration
    - 9.3.2.2.4. By End User
- 9.3.3. South Africa Food Allergy Treatment Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Allergen Type
    - 9.3.3.2.2. By Drug Type
    - 9.3.3.2.3. By Route of Administration
    - 9.3.3.2.4. By End User

10. South America Food Allergy Treatment Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Allergen Type
- 10.2.2. By Drug Type
- 10.2.3. By Route of Administration
- 10.2.4. By End User
- 10.2.5. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Food Allergy Treatment Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Allergen Type
    - 10.3.1.2.2. By Drug Type
    - 10.3.1.2.3. By Route of Administration
    - 10.3.1.2.4. By End User
- 10.3.2. Colombia Food Allergy Treatment Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Allergen Type
    - 10.3.2.2.2. By Drug Type
    - 10.3.2.2.3. By Route of Administration
    - 10.3.2.2.4. By End User
- 10.3.3. Argentina Food Allergy Treatment Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Allergen Type
    - 10.3.3.2.2. By Drug Type
    - 10.3.3.2.3. By Route of Administration
    - 10.3.3.2.4. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Food Allergy Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Aimmune Therapeutics
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. DBV Technologies
15.3. Regeneron
15.4. Sanofi
15.5. Nestle Health Science
15.6. Novartis
15.7. Immune Design
15.8. TanGenix
15.9. Allergen Labs
15.10. FARE-associated Innovators